CLINICAL_TRIALS
trial_result
· 2012-03-28
Clinical Trial Update: Caverject User Study [Phase 3]
Summary
Phase 3 results for a Caverject (alprostadil) erectile dysfunction trial were posted in 2012, providing an update on its efficacy and safety outcomes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED | Results posted: 2012-03-28